default author photo

Lorenzo Gerratana

University of Udine - Deparment of Medicine (DAME)

SCHOLARLY PAPERS

4

DOWNLOADS

350

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Efficacy and Safety of Systemic Therapies Following Progression on CDK4/6 Inhibitors in Patients with HR+/HER2-- Metastatic Breast Cancer: A Systematic Review and Network Meta-Analysis

Number of pages: 35 Posted: 13 Jun 2025
Roberto Buonaiuto, Mario Fordellone, Aldo Caltavituro, Maria L. Cataldo, Carmen Criscitiello, Maria Vittoria Dieci, Matteo Lambertini, Andrea Botticelli, Mario Giuliano, Antonio Giordano, Federica P. Mangiacotti, Angela Grieco, Alessandra Longobardi, Roberta Caputo, Martina Pagliuca, Claudio Vernieri, Luca Malorni, Lorenzo Gerratana, Maria Grazia Arpino, Paolo Chiodini, Michelino De Laurentiis and Carmine De Angelis
Scuola Superiore Meridionale, Vanvitelli University of Campania Luigi Vanvitelli, University of Naples Federico II, Baylor College of Medicine, University of Milan, University of Padova, University of Genova - Department of Internal Medicine and Medical Specialties (DiMI), Sapienza University of Rome, Baylor College of Medicine, Harvard University - Dana-Farber Cancer Institute, University of Naples Federico II, University of Naples Federico II, University of Naples Federico II, Fondazione IRCCS Istituto Nazionale dei Tumori, Gustave Roussy, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda USL Toscana Centro - Sandro Pitigliani Translational Research Unit, University of Udine - Deparment of Medicine (DAME), University of Naples Federico II, Vanvitelli University of Campania Luigi Vanvitelli, IRCCS-Fondazione Bietti and Baylor College of Medicine
Downloads 146 (505,974)

Abstract:

Loading...

HR+/HER2- metastatic breast cancer, CDK4/6 inhibitor resistance, Systematic Review, Network meta-analysis, Biomarker-driven therapy, Antibody-drug conjugates

2.

Efficacy of Baseline Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA) for Evaluation of Tumor Heterogeneity and Clinical Outcome in Advanced Breast Cancer

Number of pages: 27 Posted: 14 Sep 2022
Qiang Zhang, Zheng Cai, Lorenzo Gerratana, Andrew A. Davis, Paolo D’Amico, Saya Jacob, Youbin Zhang, Wenan Qiang, Amir Behdad, Carolina Reduzzi, Marwa Manai, Lisa Flaum, Ami N. Shah, William J. Gradishar and Massimo Cristofanilli
Northwestern University - Division of Hematology Oncology, University of Washington - Department of Biostatistics, University of Udine - Deparment of Medicine (DAME), Washington University in St. Louis - Department of Medicine, European Institute of Oncology (IEO) IRCCS, Northwestern University - Division of Hematology Oncology, Northwestern University - Division of Hematology Oncology, Northwestern University - Department of Obstetrics and Gynecology, Northwestern University - Department of Pathology, Cornell University - Division of Hematology and Oncology, Cornell University - Division of Hematology and Oncology, Northwestern University - Division of Hematology Oncology, Northwestern University - Division of Hematology Oncology, Northwestern University - Division of Hematology Oncology and Cornell University - Division of Hematology and Oncology
Downloads 101 (684,672)

Abstract:

Loading...

Circulating Tumor Cells, Circulating Tumor DNA, Metastatic Breast Cancer, Anatomical Staging

3.

Time-Varying Hazard Rates Reveal Patterns of Progression in HR+/HER2- Metastatic Breast Cancer: Towards Risk-Adapted Monitoring

Number of pages: 24 Posted: 21 Aug 2025
Linda Cucciniello, Fabiola Giudici, Lorenzo Foffano, Alessandra Franzoni, Brenno Pastò, Elisabetta Molteni, Serena Della Rossa, Gaetano Pascoletti, Simon Spazzapan, Lorena Musco, Gabriele Di Giustino, Lucia Da Ros, Riccardo Vida, Elena Poletto, Elena Nascimbeni, Marta Bonotto, Alessandro Marco Minisini, Barbara Belletti, Giuseppe Damante, Lorenzo Gerratana and Fabio Puglisi
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Ospedale Santa Maria della Misericordia, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Università degli Studi di Udine, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Ospedale Santa Maria della Misericordia, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Ospedale Santa Maria della Misericordia, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Ospedale Santa Maria della Misericordia, Ospedale Santa Maria della Misericordia, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Università degli Studi di Udine, University of Udine - Deparment of Medicine (DAME) and Università degli Studi di Udine
Downloads 57 (989,921)

Abstract:

Loading...

breast cancer, monitoring strategies, precision medicine

4.

Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the Fda Adverse Event Reporting System

Number of pages: 22 Posted: 15 Nov 2023
Sara Cecco, Stefano Puligheddu, Michele Fusaroli, Lorenzo Gerratana, Miao Yan, claudio zamagni, Fabrizio De Ponti and emanuel raschi
Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, University of Bologna, University of Bologna, University of Udine - Deparment of Medicine (DAME), Central South University - Department of Pharmacy, Regione Emilia-Romagna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna and University of Bologna
Downloads 46 (1,109,210)

Abstract:

Loading...

Antibody-drug conjugates, adverse event, pharmacovigilance, trastuzumab-deruxtecan, trastuzumab-emtansine, Sacituzumab govitecan, disproportionality analysis